Relationship between Tei index of myocardial performance and left ventricular geometry in Nigerians with systemic

Adeseye A Akintunde1, Patience O Akinwusi, George O Opadijo

  • 1Division of Cardiology, Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Nigeria. adeseyeakintunde@hotmail.com

Insights

The Tei index, measuring heart function, is impaired in hypertensive Nigerians across all left ventricular geometry types. This impairment is most severe in those with concentric and eccentric hypertrophy.

Area of Science:

  • Cardiology
  • Echocardiography
  • Hypertension Research

Background:

  • Left ventricular geometry impacts cardiovascular events and prognosis.
  • The Tei index assesses myocardial performance, reflecting systolic and diastolic dysfunction.
  • Its relation to left ventricular geometry in hypertensive populations is understudied.

Purpose of the Study:

  • To investigate the association between the Tei index and left ventricular geometry in Nigerian hypertensive subjects.
  • To evaluate cardiac function using the Tei index in relation to different hypertensive heart disease patterns.

Main Methods:

  • Echocardiography was performed on 164 hypertensive patients and 64 controls.
  • Subjects were categorized into four left ventricular geometry patterns.
  • The Tei index was calculated as (isovolumic relaxation time + isovolumic contraction time) / ejection time.

Main Results:

  • Hypertensive patients showed significantly higher Tei index values compared to controls.
  • Concentric hypertrophy, concentric remodelling, and eccentric hypertrophy groups had elevated Tei index values.
  • The Tei index correlated with ejection fraction, fractional shortening, and mitral E/A ratio.

Conclusions:

  • All hypertensive subgroups exhibited impaired left ventricular systolic and diastolic function, indicated by the Tei index.
  • The most advanced impairment was observed in patients with concentric and eccentric hypertrophy.
  • Left ventricular geometry is a significant factor in the functional decline associated with hypertension.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...